Skip to main content

Inorganic Scintillators Market worth 330.7 Million USD by 2021

The report “Inorganic Scintillators Market by Scintillation Material (NaI, CsI, LSO & LYSO), Type (Alkali Halides, Rare Earth Metals), & Application (Healthcare, Homeland Security & Defense, Nuclear Power Plants) – Analysis & Global Forecast to 2021″, This report studies the global inorganic scintillators market for the forecast period of 2016 to 2021. This market is expected to reach USD 330.7 Million by 2021 from USD 256.1 Million in 2016, growing at a CAGR of 5.2%. The global inorganic scintillators market is segmented on the basis of scintillation material, type, application, and region.

Browse 76 market data Tables and 49 Figures spread through 165 Pages and in-depth TOC on “Inorganic Scintillators Market by Scintillation Material (NaI, CsI, LSO & LYSO), Type (Alkali Halides, Rare Earth Metals), & Application (Healthcare, Homeland Security & Defense, Nuclear Power Plants) – Analysis & Global Forecast to 2021”

By scintillation material, the inorganic scintillators market is categorized into Sodium Iodide (NaI), Cesium Iodide (CsI), Lutetium Oxyorthosilicate (LSO) and Lutetium-yttrium Oxyorthosilicate (LYSO), Bismuth Germanate Oxide (BGO), Others [Barium Fluoride (BaF2), Lead Tungstate (PbWO4), Cadmium Tungstate (CdWO4), Cerium Bromide (CeBr3), Lanthanum Bromide (LaBr3), and Gadolinium Orthosilicate (GSO)]. The sodium iodide (NaI) segment is expected to command the largest share of the global inorganic scintillators market, by scintillation material in 2016. This is attributed to factors such as rising application horizon of sodium iodide, rise in homeland security expenditure to combat terrorism worldwide, and increasing number of nuclear power plants. However, the lutetium oxyorthosilicate (LSO) & lutetium-yttrium oxyorthosilicate (LYSO) segment is expected to grow at the highest CAGR during the forecast period. This is mainly due to its benefits over other scintillators, increasing research activities in the field of high-energy and nuclear physics, and rising demand for PET scanners worldwide. Due to distinguished properties of LSO and LYSO, especially their higher light output and short decay time as compared to BGO, they can potentially replace BGO in many applications.


On the basis of type, the global inorganic scintillators market is segmented into alkali halides, oxide compounds, and rare earth halides. The alkali halides segment is expected to account for the largest share of the global inorganic scintillators market in 2016. This can be attributed to the rising application horizon of alkali halides, increase in the research activities for space exploration, rise in government defense budgets, and growing need for environmental radiation testing. However, the rare earth metals segment is projected to grow at the highest CAGR from 2016 to 2021. This can be attributed to its high light yield, energy resolution crystals, faster response times, and good gamma ray-stopping efficiency, and improved decay time (as compared to alkali halides).

On the basis of application, the inorganic scintillators market is segmented into healthcare, homeland security and defense, nuclear power plants, industrial, and other applications (high-energy physics, astrophysics, environmental monitoring, and academic research). In 2016, the healthcare segment is expected to command the largest share of the global inorganic scintillators market, by application. This can be attributed to the increasing incidence of cancer, rising research activity, increasing installations of PET scanners worldwide, and growing preference for effective radiation protection in medical facilities. However, the homeland security and defense segment is projected to grow at the highest CAGR from 2016 to 2021. Rising terrorism levels globally, growing government initiatives by governments worldwide to improve homeland security, and increasing security and defense expenditure are expected to augment the demand for inorganic scintillators in the homeland security and defense industry in the coming years.


On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is poised to account for the largest share of the inorganic scintillators market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period. Factors such as high spending on homeland security in Asia, the Japanese government’s decision to reverse its nuclear power phase-out, high expected growth in China’s nuclear power industry, presence of global and local players in the Chinese market, increasing number of nuclear power plants in India, and increasing installations of nuclear imaging systems in India are expected to propel the growth of the inorganic scintillators market in the Asia-Pacific region.

Growing safety concerns post the Fukushima disaster, growing security threats, growing security budgets of global sporting events, increasing incidence of cancer, growth in the number of PET/CT scans, and growing threat of nuclear terrorism are expected to drive the growth of the global inorganic scintillators market in the coming years.

Saint-Gobain S.A. (France), Hamamatsu Photonics K.K. (Japan), Dynasil Corporation of America (U.S.), Hitachi Metals Group (Japan), Rexon Components, Inc. (U.S.), Detec (Canada), Toshiba Materials Co., Ltd. (Japan), Scintacor (U.K.), EPIC Crystal Company Limited (China), Amcrys (Ukraine), Alpha Spectra, Inc. (U.S.), Shanghai SICCAS High Technology Corporation (China), and Nihon Kessho Kogaku Co., Ltd. (Japan) are some of the key players in the inorganic scintillators market worldwide.


About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

                           https://healthcaredc.wordpress.com
Labels:

Comments

Post a Comment

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...
Post a Comment
Read more

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...
Post a Comment
Read more

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...
Post a Comment
Read more